Such a strategy has been suggested by the Baier group who demonstrated the importance of NR2F6 as an intracellular immune checkpoint in effector T cells (55) and later showed that mice genetically deficient in NR2F6 and then inoculated with tumor cells exhibit relatively decreased tumor growth (31, 32). Here, NR2F6 is linked to neoplasm.